Compile Data Set for Download or QSAR
Report error Found 201 Enz. Inhib. hit(s) with all data for entry = 939
TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300273BDBM300273(US9593110, Example 2-11)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299642BDBM299642(US9593110, Example 87b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299643BDBM299643(US9593110, Example 13 | (2R,4R)-2-Amino-5-(5′...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300275BDBM300275(US9593110, Example 2-12)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300276BDBM300276(US9593110, Example 18-10)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299645BDBM299645(US9593110, Example 88b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300277BDBM300277(US9593110, Example 2-13)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300278BDBM300278(US9593110, Example 18-11)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299647BDBM299647(US9593110, Example 15 | (2R,4R)-2-Amino-5-(5′...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300279BDBM300279(US9593110, Example 2-14)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299648BDBM299648(US9593110, Example 89b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299633BDBM299633(US9593110, Example 8 | (2S,4S)-5-(3′-Chlorob...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299634BDBM299634(US9593110, Example 28 | (2S,4S)-2-(Acetylaminometh...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300266BDBM300266(US9593110, Example 2-8)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299635BDBM299635(US9593110, Example 29 | (2R,4R)-5-(5′-Chloro...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300267BDBM300267(US9593110, Example 18-6)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299636BDBM299636(US9593110, Example 83b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300268BDBM300268(US9593110, Example 2-9)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299637BDBM299637(US9593110, Example 84b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299638BDBM299638(US9593110, Example 85a)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299639BDBM299639(US9593110, Example 10 | (2S,4S)-5-Biphenyl-4-yl-2-...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300271BDBM300271(US9593110, Example 18-8)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300272BDBM300272(US9593110, Example 62)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299657BDBM299657(US9593110, Example 93b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299659BDBM299659(US9593110, Example 94b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300292BDBM300292(US9593110, Example 7-1)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299661BDBM299661(US9593110, Example 95b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299662BDBM299662(US9593110, Example 40 | (2R,4R)-2-(4-Aminobutyryla...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300294BDBM300294(US9593110, Example 7-2)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299664BDBM299664(US9593110, Example 96b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300295BDBM300295(US9593110, Example 7-3)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300296BDBM300296(US9593110, Example 7-4)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299649BDBM299649(US9593110, Example 90b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300281BDBM300281(US9593110, Example 2-15)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300282BDBM300282(US9593110, Example 2-16)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299651BDBM299651(US9593110, Example 33 | (2R,4R)-2-(2-Aminoacetylam...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300283BDBM300283(US9593110, Example 21-1)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299652BDBM299652(US9593110, Example 91b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300284BDBM300284(US9593110, Example 4-1)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299654BDBM299654(US9593110, Example 92b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300286BDBM300286(US9593110, Example 4-2)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300287BDBM300287(US9593110, Example 21-3)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300288BDBM300288(US9593110, Example 4-3)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299674BDBM299674(US9593110, Example 48a)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300305BDBM300305(US9593110, Example 7-11)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300307BDBM300307(US9593110, Example 9-1)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299677BDBM299677(US9593110, Example 102b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300308BDBM300308(US9593110, Example 9-2)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299678BDBM299678(US9593110, Example 49a)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 300309BDBM300309(US9593110, Example 30-1)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 201 total ) | Next | Last >>
Jump to: